Microdosing psychedelics like psilocybin may enhance your mental health and overall well-being. Heres how.
When you think of magic mushrooms, you might think of vibrant colors, hippies, and trippy visuals. But recent research (and centuries of anecdotal evidence) indicates that psychedelics may have greater potential to help improve mental health.
Whats more, you may not have to take high doses of psychedelics to tap into their perks. Microdosing substances like psilocybin can offer mental health benefits without experiencing hallucinations. However, it still may be possible to experience hallucinations or even negative side effects like a bad trip while microdosing.
Psych Central interviewed Oregon-based psychotherapist and co-founder of Yale Psychedelic Science Group Peter H. Addy, PhD, LPC, LMHC, who specializes in psychedelic harm reduction and integration work. Addy discussed how microdosing psilocybin can impact your mental well-being.
Microdosing describes using a psychoactive substance at a dose lower than whats needed for recreational use. With such low amounts, the substances effects arent felt strongly enough to impair your senses.
With microdosing, approximately 1/10th to 1/20th of a recreational dose is taken, usually with the intention of improving your well-being and enhancing cognitive and emotional processes.
For dried, well-preserved Psilocybe cubensis mushrooms, a recreational dose might be 1 to 5 grams. So, a microdose might be 1/20th to 1/10th of 1 gram, Addy explains. Its very small, and you need a scale accurate to 0.001 g to measure such a small amount of material.
Microdosing can also involve participating in multiple dosing sessions.
In addition to psilocybin, you can microdose LSD, MDMA, and other psychedelics, as well.
According to Addy, microdosing doesnt actually feel like anything which is ultimately the point.
On the off days day 2 and 3 when you arent taking a microdose, you might feel more focused and productive, he adds.
On the other hand, higher doses of psilocybin may induce the following experiences:
The most common way is to microdose every third day for 30 days. You take a dose in the morning on day 1, nothing for day 2 and 3, and microdose again on day 4, Addy explains. This is also known as the Fadiman protocol.
Another strategy is the Stamets protocol, named after the famous mycologist Paul Stamets. [Youd] microdose 4 days in a row then take 3 days off (microdose Monday through Thursday then take a break Friday through Sunday, for example), says Addy.
With microdosing, the substance youre using is typically taken in the morning on an empty stomach or with a light snack.
Addy notes that possessing and using psilocybin mushrooms in the United States is illegal (yes, even in Oregon where its recently been decriminalized).
To take psychedelics as safely and legally as possible, you can consider:
There may be many potential short- and long-term benefits of taking low doses of psychedelics like psilocybin.
A 2020 study suggests that less than 1 to 3 milligrams (mg) of LSD and psilocybin can subtly improve cognitive processes, like:
Another 2020 survey conducted with people who have had psychedelic experiences as a form of self-therapy suggests the following short-term benefits of microdosing:
A 2020 analysis compiling anecdotal evidence from a subreddit on self-reported experiences of microdosing psychedelics shares similar benefits:
Addy adds that long-term benefits at the end of a 30-day microdosing procedure might include:
Microdosing studies are limited at this time. But the research we do have suggests that it may offer relief for people who live with anxiety and depression.
A common question is whether mushrooms have placebo effects. Addy highlights the following three studies that do a good job of examining this concept:
We dont know very much about microdosing, but at least some of the time it might be expectation and intention that leads to change, not microdosing, he explains.
Whether it is a placebo effect at play, people have been known to report relief after microdosing psilocybin.
According to Addy, those who may be best suited to try microdosing psilocybin include people:
A 2020 study suggests that small doses of psychedelics are generally well tolerated and have none-to-minimal effects on your body. But there are still potential risks that you may want to be aware of before you try microdosing.
According to the same study, some participants also experienced negative side effects, like increased anxiety and a cycling pattern between depressive and euphoric moods.
If youve never tried microdosing before, considering some safety reminders and harm reduction strategies may be helpful as a precaution.
First and foremost, psychedelics arent totally legal yet.
The main risk is that psilocybin is illegal to have and use, despite having a low potential for abuse and currently accepted as medical use, says Addy. Being arrested, fined, imprisoned, or losing work arent conducive to mental health or personal growth.
Its important to be careful of your set, setting, and dosage. Plant medicines arent like taking Tylenol, reminds Addy. Each dose is a little different, and you might accidentally take a little too much and then have to go to work or interact with your family.
In terms of the potentially negative side effects of microdosing, Addy says people sometimes report experiencing:
He notes that moving, stretching, or exercising right after microdosing can help reduce anxiety and physical discomfort. Meditating afterward can also help with focus and creativity, too.
One survey asked people who have microdosed if they talked about it with their doctors or therapists, and only 18% had done so, says Addy.
If youre microdosing or thinking about microdosing in the future, it can be beneficial to find a doctor or therapist you trust enough to discuss your intentions and use. However, its important to understand that these substances are still illegal in most countries and remain unapproved by the Food and Drug Administration (FDA).
Studies on the therapeutic benefits of microdosing psychedelics are limited and in progress. But research suggests that microdosing psilocybin may help improve mental health and help treat some mental health conditions, like anxiety and depression.
There are still potential benefits and risks to be aware of before microdosing, though.
Firstly, its important to remember that psychedelics like psilocybin are not legal in the United States just yet, even in places like Oregon where the substance has been decriminalized.
If youre considering microdosing psilocybin, talking with a doctor or therapist about whether microdosing or psychedelic therapy may be right for you can be a good starting point.
See the original post:
What Is Microdosing and Can It Help Mental Health? - PsychCentral.com
- VA Studying Psychedelics As Mental Health Treatment For Veterans - Forbes - June 29th, 2022
- 10 Psychedelics CEOs To Pay Attention To In 2022 - Yahoo Finance - June 29th, 2022
- Secret ancient Andean passageways may have been used in rituals involving psychedelics - Livescience.com - June 29th, 2022
- How psychedelics act on the brain to relieve depression - Daily Maverick - June 29th, 2022
- Magic mushrooms are all the rage. But are they Jewish? - The Guardian - June 29th, 2022
- Treating Stress with Wearable Technology - Psychedelic Spotlight - June 29th, 2022
- Numinus Applies for International Patent Filing of Psychedelics Production Process - PR Newswire - June 29th, 2022
- This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More! - Psychedelic Spotlight - June 29th, 2022
- Is there a future for psychedelic treatment in Saudi Arabia? - Arab News - June 29th, 2022
- Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA - Marketscreener.com - June 29th, 2022
- Braxia Scientific CEO to Deliver Keynote Address at HC Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and... - June 29th, 2022
- Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review - Cureus - June 29th, 2022
- How an NHL Enforcer Broke His Body and Turned to Psychedelics to Heal His Brain - Rolling Stone - June 22nd, 2022
- The top psychedelic drug developers leading the market - Labiotech.eu - June 22nd, 2022
- Numinus Applies for International Patent Filing of Psychedelics Production Process - Yahoo Finance - June 22nd, 2022
- Two psychedelic-related initiatives may be on the 2022 Colorado ballot - Denver 7 Colorado News - June 22nd, 2022
- Cybin Inc. Reports Fiscal Year 2022 Financial Results and Recent Business Highlights - Business Wire - June 22nd, 2022
- SPOTLIGHT IN FOCUS - The Rise of Psychedelic Therapy - Psychedelic Spotlight - June 22nd, 2022
- Rapper Vic Mensa has a more badass fitness routine than you thanks to martial arts, psychedelics and meditation - British GQ - June 22nd, 2022
- What is Ego Death And How Does it Work? - Benzinga - Benzinga - June 22nd, 2022
- Anecdotal Evidence and the Need for Trials of Psychedelics in Headache Disorders: Bryan Roth, MD, PhD - Neurology Live - June 11th, 2022
- Stephen Asma: My father's experience with morphine in hospice showed me the healing joy of altered states - Chicago Tribune - June 11th, 2022
- TDR's Top 5 Psychedelic Developments For The Week Of May 30 - The Dales Report - June 5th, 2022
- Psychedelic Wellness: 5 Magical Benefits of Magic Mushrooms - Longevity LIVE - Longevity LIVE - June 5th, 2022
- 'Magic mushrooms drug could help depression sufferers in the years to come' - Irish Mirror - June 5th, 2022
- Tripping over the potential of psychedelics for autism | Spectrum - Spectrum - June 3rd, 2022
- Can you take the trip out of psychedelics and still treat depression? - New Scientist - June 3rd, 2022
- We spark curiosity: how the psychedelics industry is taking on Davos - The Guardian - June 3rd, 2022
- Cybin Announces Publication in Frontiers in Psychology Journal Introducing EMBARK, an Integrative Model of Psychedelic Therapy - Business Wire - June 3rd, 2022
- Ketamine can treat depression but teletherapy could make it accessible - Inverse - June 3rd, 2022
- 2022-06-01 | PINL:EHVVF | Press Release | ehave Inc - Stockhouse - June 3rd, 2022
- VIDEO: The Weekly Weed Report (05-31-22) - Investing Daily - Investing Daily - June 3rd, 2022
- Psychedelics Companies in Oregon Will Have to Grapple With 280E - Business Insider - May 21st, 2022
- TDR's Top 5 Psychedelic Developments For The Week Of May 16 - The Dales Report - May 21st, 2022
- Psychedelics and Mindfulness: The Future of Mental Health? | Microdose - Microdose Psychedelic Insights - May 21st, 2022
- CATALYST Summit: 3 Psychedelic Speakers to Catch This Weekend - Psychedelic Spotlight - May 21st, 2022
- 'I took ketamine to treat my severe depression' - iNews - May 21st, 2022
- TDR's Top 5 Psychedelic Developments For The Week Of May 9 - The Dales Report - May 15th, 2022
- Psychedelic Patents are Broken Because the Patent System Is Broken - VICE - May 15th, 2022
- Magic mushrooms are on WeHos mind - WEHOville - May 15th, 2022
- Behind the Scenes on the First Study To Compare the Effects of LSD and Psilocybin - Technology Networks - May 15th, 2022
- Revitalist's Strategic Initiatives Continue to Exceed Expectations for Execution Giving Company Record High Revenues Since Opening in 2018. - Business... - May 15th, 2022
- MDMA as medicine: Stemming the tide of veteran suicides in Western North Carolina - Smoky Mountain News - May 15th, 2022
- Cybin's CYB0004 Shows Positive Preclinical Results Over ... - May 3rd, 2022
- Psychedelics played role in Wallace Falls hiker's death ... - May 3rd, 2022
- The Mainstream Healthcare VCs Dipping Their Toes Into Psychedelics - Business Insider - May 3rd, 2022
- LSD Is Back On Campus, But This Time It's Approved - Green Market Report - May 3rd, 2022
- Mixing mushrooms and alcohol: What you need to know - Medical News Today - May 3rd, 2022
- Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market - GlobeNewswire - May 3rd, 2022
- Pharmadrug Advances Opthalmology Program with Final Selection of Lead DMT-Analogue to Provide Sustained Control of Elevated Intraocular Pressure for... - May 3rd, 2022
- Bicycle Day: Honoring The Onset Of The Psychedelic Revolution As It Zooms Across The Globe - Forbes - April 15th, 2022
- Psilocybin Rewires the Brain for People with Depression - University of California, San Francisco - April 15th, 2022
- Field Trip Health Houston's psychedelic healing with ketamine helps patient with depressive anxiety - Houston Chronicle - April 15th, 2022
- Mental Health Week: Magnetic Stimulation, Psychedelics and Tai Chi How Treatments For Anxiety And Depression Are Growing - KPCC - April 15th, 2022
- Psychedelics Want To Win Over The Sleep Aid Market - Green Market Report - April 15th, 2022
- Terran Biosciences and Blumentech SL announce the acquisition of a patent portfolio covering the groundbreaking discoveries of prominent psychedelics... - April 15th, 2022
- Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other Psychedelic Compounds - Yahoo Finance - April 15th, 2022
- Experts discuss the intersections of cannabis, health and food - CSU Pueblo Today - April 15th, 2022
- Psychedelics - PMC - April 11th, 2022
- Psychedelics - PubMed - April 11th, 2022
- Peace with psychedelics: Palestinians, Israelis took ayahuasca - Big Think - April 11th, 2022
- Study maps psychedelic-induced changes in consciousness to specific regions of the brain - PsyPost - April 11th, 2022
- The Next Big Addiction Treatment - The New York Times - April 11th, 2022
- SABI Mind and Reverie Psychedelics Partner To Expand Research Into Psychedelic-Assisted Therapies - Benzi - Benzinga - April 11th, 2022
- Jaden Smith on His Trippy Summer '22 Collection and the Power of Mushrooms - Complex - April 11th, 2022
- Biomind Labs to Present at Benzinga Psychedelics Capital Conference in the U.S. on April 19th 2022 - Business Wire - March 31st, 2022
- Psychedelics' Interaction With Psych Meds: More Q's Than A's - Medscape - March 31st, 2022
- The Insights Psychedelics Give You Arent Always True - March 18th, 2022
- Stage Set for Psychedelics Stock Boom: Here's Where ... - March 18th, 2022
- SXSW stage is a collision of weed, metaverse, NFTs, acid and saving the planet - PitchBook News & Analysis - March 18th, 2022
- Jaden Smith Recalls His Experience With Psychedelic Mushrooms: Everything Just Becomes So Beautiful - Koimoi - March 18th, 2022
- Michigan Activists Submit Psychedelics Decriminalization ... - March 17th, 2022
- Psychedelics and the Future of Psychiatry - March 17th, 2022
- Mind Cure Gives Up On Psychedelics, Fires C-Suite, And Reverts To Shell After Strategic Review - The Deep Dive - March 17th, 2022
- A Fully-Seated Audience Takes Post-Punk with the Psychedelic Furs - Cornell University The Cornell Daily Sun - March 17th, 2022
- 5 people who used psychedelics to treat PTSD describe their trips - Business Insider - March 15th, 2022
- What is Microdosing, and Does it Work? - The New York Times - March 15th, 2022
- Bolt's Breslow Teams With Psychedelics Founder on Crypto Pharma Startup - The Information - March 15th, 2022
- Enveric, University of Calgary to study psychedelic therapy - OutSourcing-Pharma.com - March 15th, 2022
- Psychedelic therapy integral to ancient societies may be coming to Pennsylvania - 90.5 WESA - March 15th, 2022